CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 10 No. 9
 

Two Studies Conclude That PCR Testing for HIV is Warranted in Infants but Not Adults

September 1, 1996

Polymerase chain reaction (PCR) testing, which is much more expensive than AIDS antibody tests, should be used routinely to detect HIV infection in infants but not in adults, according to two new studies from Veterans Affairs and Stanford researchers.

"We found that PCR is not as accurate as antibody tests in adults, but in infants it's one of the best tests available," said Dr. Douglas Owens, health services senior research associate at the Veterans Affairs Palo Alto Health Care System and assistant professor of medicine and of health research and policy at Stanford University School of Medicine.

Researchers led by Owens and Dr. Mark Holodniy reported their findings in the May 1 issues of the Annals of Internal Medicine and the Journal of the American Medical Association. They based their conclusions on analyses of 96 studies that evaluated PCR screening for HIV in adults and 32 studies looking at the technique in infants.

Unlike antibody tests, which detect molecules formed by the immune system in response to HIV, PCR is a newer method that detects viral genes in a blood sample. Within hours, this technique can turn a tiny shred of genetic material into millions of easily analyzed copies.

Method's Worth Has Been Debated

When PCR became available about 10 years ago, Owens said, many physicians hoped it could be a useful test for HIV infection in both infants and adults--despite its expense. Since then, the method has become controversial, as numerous studies have failed to agree on its value in HIV testing. "Some studies indicated PCR testing was perfect, while others indicated it was inaccurate," Owens noted.

To help settle the issue, Owens and his colleagues performed a meta-analysis on data from a number of smaller studies. The researchers concluded that antibody tests are more accurate than PCR in adults and recommended adult PCR testing in only a few situations. For example, PCR may help detect HIV in people exposed so recently that their bodies haven't yet generated antibodies against the virus.

For infants, however, the researchers concluded that PCR is very useful in diagnosing HIV infection. All babies born to mothers with HIV have maternal antibodies against the virus in their blood for about 15 to 18 months, and therefore, antibody tests cannot tell physicians whether a newborn is actually infected, Owens noted.

Although PCR is one of the most accurate tests for use in infants, he said, a single test result is not sufficient to make or exclude the diagnosis. Rather, doctors should follow the infant closely for signs of HIV infection.

PCR Accuracy Depends Partly on Age

The accuracy of PCR depends, in part, on the child's age, Owens explained. "Current thinking is that a baby often is infected during birth, and it takes a while for the numbers of virus to build," he said. The researchers recommend using PCR after a child is 30 days old or repeating the test if it is used in newborns.

In addition to Owens and Holodniy, who directs the AIDS research center at the Palo Alto VA, coauthors of the JAMA report on adult studies were Dr. Thomas McDonald, John Scott, and Seema Sonnad. The Annals coauthors, along with Owens, Holodniy, Scott, and Sonnad, were Dr. Alan Garber, Lincoln Moses, Dr. Bruce Kinosian, and Dr. J. Sanford Schwartz.

The research was supported by the U.S. Department of Veterans Affairs and the National Institutes of Health.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy